• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsBasic MaterialsChemicalsCosmo Chemical
    Picture of Cosmo Chemical logo

    005420 — Cosmo Chemical Share News

    KR₩10,4700.000.00%
    kr flag iconLast trade - 00:00
    Basic MaterialsHighly SpeculativeSmall CapSucker Stock
    • Market Cap
      KR₩402bn
    • Enterprise Value
      KR₩1tn
    • Revenue
      KR₩664bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 005420 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    005420 Dividends
    • Brief: Cosmo Chemical Co Ltd Wins 15.5 Billion Won Order

      09/06/2026 01:55
    • US to award $3 billion to 25 projects for battery manufacturing sector

      20/09/2024 10:00
    • Brief: Cosmo Chemical Co Ltd Wins 799 Billion Won Order

      26/03/2024 02:33
    • Brief: Cosmo Chemical To Conduct Capital Increase Of 117.5 Billion Won

      18/08/2023 10:49
    • Brief: Cosmo Chemical To Invest 70 Billion Won In Facility Expansion

      18/08/2023 10:48
    • Brief: Cosmo Chemical Wins 43 Billion Won Order

      31/01/2023 05:03
    • Brief: Cosmo Chemical To Invest 15.9 Billion Won In Lithium Carbonate Production Facility

      21/06/2022 01:52
    • Advisory: Alerts on Cosmo Chemical H1 results withdrawn

      30/07/2020 06:17
    • Refile: BRIEF-Cosmo Chemical To Reduce Capital From $67 Mln To $13 Mln

      23/08/2019 08:40
    • Brief: Cosmochemical to sell entire stake in marumankorea for 21.21 bln won

      30/06/2017 11:40
    • Brief: Cosmo Chemical to issue 22th series convertible bonds worth 6 bln won

      28/06/2017 03:02
    • CEO

      27/03/2017 03:15
    • Brief: Cosmo Chemical to sell properties for 46.09 bln won

      29/08/2016 09:43
    • Brief: Cosmo: successful outcome of phase III clinical trial for Rifamycin SV MMX

      06/06/2016 06:01

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.